QCM
REGN icon

Quantinno Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quantinno Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.3M Buy
48,251
+9,590
+25% +$7.34M 0.06% 383
2025
Q4 		$29.8M Buy
38,661
+7,686
+25% +$5.22M 0.06% 378
2025
Q3 		$17.4M Buy
30,975
+15,366
+98% +$8.69M 0.05% 443
2025
Q2 		$8.19M Buy
15,609
+5,513
+55% +$3.08M 0.04% 617
2025
Q1 		$6.4M Buy
10,096
+5,065
+101% +$3.48M 0.04% 545
2024
Q4 		$3.58M Sell
5,031
-2,442
-33% -$2.05M 0.04% 612
2024
Q3 		$7.86M Buy
7,473
+2,798
+60% +$3.11M 0.1% 196
2024
Q2 		$4.91M Buy
4,675
+637
+16% +$618K 0.09% 246
2024
Q1 		$3.89M Buy
4,038
+985
+32% +$937K 0.08% 274
2023
Q4 		$2.68M Sell
3,053
-213
-7% -$175K 0.09% 271
2023
Q3 		$2.69M Buy
3,266
+857
+36% +$674K 0.12% 196
2023
Q2 		$1.73M Sell
2,409
-68
-3% -$52.4K 0.1% 261
2023
Q1 		$2.04M Buy
2,477
+500
+25% +$377K 0.13% 186
2022
Q4 		$1.43M Buy
1,977
+1,372
+227% +$1.01M 0.11% 274
2022
Q3 		$417K Sell
605
-24
-4% -$15.1K 0.05% 418
2022
Q2 		$372K Sell
629
-15
-2% -$9.75K 0.05% 406
2022
Q1 		$450K Buy
+644
New +$407K 0.07% 323

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Quantinno Capital Management's REGN Position: Q1 2026 in Review

Quantinno Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 25% in Q1 2026, buying an estimated $7.34M and bringing the position to 48,251 shares worth $37.3M. The position accounts for 0.06% of the portfolio, ranked #383.

Quantinno Capital Management first reported a position in REGN in Q1 2022 and has held it in 17 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Quantinno Capital Management held 48,251 shares of Regeneron Pharmaceuticals worth $37.3M as of Q1 2026.
  • Quantinno Capital Management bought 9,590 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $7.34M.
  • Regeneron Pharmaceuticals made up 0.06% of Quantinno Capital Management's portfolio in Q1 2026, its #383 holding.
  • Quantinno Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.